CASI Pharmaceuticals, Inc. Business Finance Contracts & Agreements
47 Contracts & Agreements
- Assignment Agreements (1 contract)
- Equity Distribution Agreements (1)
- Exchange Agreements (4)
- Investment Agreements (6)
- Loan Agreements (2)
- Note Agreements (8)
- Pledge Agreements (1)
- Purchase Agreements (5)
- Security Agreements (1)
- Stock Agreements (7)
- Warrant Agreements (11)
- Equity Transfer Agreement between CASI Biopharmaceuticals (Wuxi) Co., Ltd. and Shenzhen Jiadao Gongcheng Equity Investment Fund (Limited Partnership) dated September 22, 2022 (Filed With SEC on November 14, 2022)
- Commercial Pledge Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)
- Commercial Security Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)
- Business Loan Agreement between the Registrant and East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)
- Promissory Note issued by the Registrant to East West Bank, dated May 23, 2022 (Filed With SEC on August 12, 2022)
- Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated October 29, 2021 (Filed With SEC on October 29, 2021)
- Description of Common Stock (Filed With SEC on March 30, 2021)
- Investment Agreement by and between Juventas Cell Therapy Ltd and CASI Biopharmaceuticals (WUXI) Co., Ltd. effective as of September 22, 2020 (Filed With SEC on November 9, 2020)
- Contract for Assignment of the Right to the Use of the State-owned Construction Land (no. 3202842019CR0019) dated November 15, 2019 (Filed With SEC on March 16, 2020)
- Description of Common Stock (Filed With SEC on March 16, 2020)
- Investment Agreement in respect of Juventas Cell Therapy Ltd. executed June 15, 2019 (Filed With SEC on August 9, 2019)
- Amendment No. 1 to Common Stock Sales Agreement by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated July 19, 2019 (Filed With SEC on July 19, 2019)
- Shareholders Agreement, dated November 16, 2018, between CASI Pharmaceuticals, Inc. and Wuxi Jintou Huicun Investment Enterprise (Limited Partnership) (Filed With SEC on March 29, 2019)
- Form of Securities Purchase Agreement (Filed With SEC on September 14, 2018)
- Form of Warrant (Filed With SEC on September 14, 2018)
- Asset Purchase Agreement, dated as of January 26, 2018, by and between CASI Pharmaceuticals, Inc. and Sandoz Inc (Filed With SEC on March 29, 2018)
- Form of Securities Purchase Agreement (Filed With SEC on March 23, 2018)
- Form of Warrant (Filed With SEC on March 23, 2018)
- Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated February 23, 2018 (Filed With SEC on February 23, 2018)
- Third Amendment to Secured Promissory Note, dated as of December 20, 2017, by and between the Company and Talon Therapeutics, Inc (Filed With SEC on December 22, 2017)
- Form of Stock Purchase Agreement (Filed With SEC on October 19, 2017)
- Form of Wainwright Warrant (Filed With SEC on October 19, 2017)
- Form of Common Stock Purchase Warrant (Filed With SEC on October 19, 2017)
- SECOND AMENDMENT TO SECURED PROMISSORY NOTE (Filed With SEC on December 16, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 13, 2015)
- FIRST AMENDMENT TO SECURED PROMISSORY NOTE (Filed With SEC on October 1, 2015)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on November 14, 2014)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on November 14, 2014)
- Confidential Materials omitted andfiled separately with the Securities and Exchange Commission. Triple asterisks denote omissions. LICENSE AGREEMENT (Filed With SEC on November 14, 2014)
- INVESTMENT AGREEMENT (Filed With SEC on September 19, 2014)
- INVESTMENT AGREEMENT (Filed With SEC on September 19, 2014)
- SECURED PROMISSORY NOTE (Filed With SEC on September 19, 2014)
- CERTIFICATE OF DESIGNATIONS OF series A preferred stock Of CASIPHARMACEUTICALS, INC. (Filed With SEC on September 19, 2014)
- FORM OF COMMON STOCK PURCHASE WARRANT entremed,inc. (Filed With SEC on March 6, 2013)
- FORM OF COMMON STOCK PURCHASE WARRANT entremed,inc. (Filed With SEC on March 6, 2013)
- CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on January 26, 2012)
- STANDBY EQUITY DISTRIBUTION AGREEMENT (Filed With SEC on June 28, 2011)
- THISEXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIALTREATMENT REQUEST PURSUANT TO RULE 24b-2. REDACTEDMATERIAL IS MARKED WITH [***] AND HAS BEEN FILED SEPARATELY... (Filed With SEC on November 12, 2010)
- FORMOF COMMONSTOCK PURCHASE WARRANT ENTREMED,INC. (Filed With SEC on September 10, 2010)
- PROMISSORY NOTE (Filed With SEC on November 8, 2007)
